Medinotec Inc.
Medinotec Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash | 3 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Accounts Receivable Net Current | 3 | 2 | 2 | 3 | 4 | 3 | 1 | 1 | 0 | 1 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 7 | 6 | 6 | 6 | 7 | 6 | 5 | 5 | 4 | 4 | 4 | 4 | |||||
Inventory Gross | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts And Notes Receivable Net | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Tax Assets Deferred Income | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Assets | 7 | 7 | 7 | 6 | 7 | 7 | 5 | 5 | 4 | 5 | 4 | 5 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | |||||
Taxes Payable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Liabilities Current | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 0 | 0 | |||||
Accrued Bonuses Current | - | - | - | - | - | - | - | 0 | 0 | 0 | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Loans Payable To Bank | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Deferred Income Tax Liabilities Net | - | - | - | - | - | 0 | - | - | - | - | - | - | |||||
Deferred Tax Liabilities | - | - | - | - | - | 0 | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Liabilities Noncurrent | |||||||||||||||||
Liabilities | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | |||||
Commitments And Contingen… | |||||||||||||||||
Additional Paid In Capital Common Stock | - | - | - | - | - | - | - | - | - | - | 3 | 3 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | - | - | |||||
Stockholders Equity | 6 | 6 | 6 | 5 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 3 | |||||
Minority Interest | 2 | 2 | 2 | 1 | 1 | 1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockholders Equity | 7 | 7 | 7 | 6 | 7 | 7 | 5 | 5 | 4 | 5 | 4 | 5 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | - | - | - | - | - | 0.001 | 0.001 | - | - | - | - | |||||
Common Stock Shares Authorized | 200 | - | - | - | - | - | 200 | 200 | - | - | - | - | |||||
Common Stock Shares Issued | 12 | - | - | - | 12 | - | 12 | 12 | - | - | - | - | |||||
Shares Outstanding | 12 | - | - | - | 12 | - | 12 | 12 | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027 | 0.00% | - | - | - | - | - | - | - | - | - | - | - |
| 2026 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | - |
| 2025 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 5.81 | 5.83 | 4.79 | 3.90 | 3.33 | 4.27 | 3.34 | 3.13 | 5.10 | 5.29 | 10.69 | 30.95 | |||||
| Quick Ratio | 4.55 | 4.71 | 3.89 | 3.25 | 2.88 | 3.61 | 2.56 | 2.32 | 3.86 | 4.25 | 8.57 | 25.81 | |||||
| Working Capital | 5.44M | 5.32M | 5.12M | 4.44M | 4.86M | 4.92M | 3.45M | 3.34M | 3.16M | 3.55M | 3.26M | 3.71M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.19 | 0.19 | 0.25 | 0.32 | 0.69 | 0.59 | 0.90 | 1.09 | 0.92 | 1.22 | 0.92 | 0.92 | |||||
| Interest Coverage TTM | 15.96 | 12.50 | 30.94 | 22.94 | 21.29 | 18.09 | 6.64 | 4.92 | 3.07 | 2.17 | 0.25 | -0.39 | |||||
| Debt Ratio | 0.16 | 0.16 | 0.20 | 0.24 | 0.41 | 0.37 | 0.47 | 0.52 | 0.48 | 0.55 | 0.48 | 0.48 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.42 | 1.43 | 1.87 | 1.96 | 1.70 | 1.57 | 1.68 | 1.43 | 1.30 | 1.08 | 0.74 | 0.36 | |||||
| Days Sales Outstanding TTM | 114.00 | 93.13 | 52.06 | 53.44 | 77.51 | 64.12 | 24.78 | 23.76 | 18.69 | 22.20 | 19.41 | 37.22 | |||||
| Receivables Turnover TTM | 3.20 | 3.92 | 7.01 | 6.83 | 4.71 | 5.69 | 14.73 | 15.36 | 19.53 | 16.44 | 18.80 | 9.81 | |||||
Per Share Metrics | |||||||||||||||||
| Free Cash Flow Per Share TTM | 0.12 | - | - | - | -0.02 | - | 0.05 | 0.08 | - | - | - | - | |||||
| Dividend Per Share TTM | 0.00 | - | - | - | 0.00 | - | 0.00 | 0.00 | - | - | - | - | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 53.90% | 52.71% | 57.94% | 55.13% | 51.34% | 52.87% | 43.77% | 44.72% | 46.53% | 48.65% | 54.12% | 67.32% | |||||
| Operating Profit Margin TTM | 9.74% | 11.25% | 29.10% | 28.81% | 32.01% | 35.02% | 18.78% | 16.54% | 14.15% | 11.96% | 2.67% | -8.04% | |||||
| Net Profit Margin TTM | 8.81% | 8.17% | 20.53% | 19.67% | 21.87% | 23.70% | 9.92% | -0.30% | -5.80% | -8.06% | -24.24% | -20.58% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 2.51% | 6.76% | 44.82% | 56.35% | 70.69% | 81.53% | 132.81% | 313.75% | - | - | - | - | |||||
| Net Income Growth (1Y) | -58.70% | -63.21% | 199.81% | -10,383.50% | -743.39% | -633.61% | -195.26% | -93.99% | - | - | - | - | |||||
| EPS Growth (1Y) | -58.70% | - | - | - | - | - | - | - | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 65.11 | - | - | - | 26.89 | - | 75.14 | -2,683.96 | - | - | - | - | |||||
| P/B TTM | 10.04 | - | - | - | 13.45 | - | 20.76 | 23.19 | - | - | - | - | |||||
| P/S TTM | 5.74 | - | - | - | 5.88 | - | 7.45 | 8.03 | - | - | - | - | |||||
| Market Cap | 58.78M | - | - | - | 58.78M | - | 58.67M | 58.67M | - | - | - | - | |||||
| Enterprise Value | 56.26M | - | - | - | 56.83M | - | 55.99M | 55.91M | - | - | - | - | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.45M | 906.80K | 1.12M | 613.55K | -213.24K | 786.13K | 600.37K | 930.12K | 526.83K | 11.99K | 345.65K | -941.17K | |||||
| Net Debt | -2.52M | -2.76M | -2.86M | -2.25M | -1.95M | -2.77M | -2.68M | -2.76M | -2.52M | -2.81M | -2.68M | -2.84M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Medinotec Inc. (MDNC) — SEC Financial Statements & Analysis
Medinotec Inc. (MDNC) is a surgical & medical instruments & apparatus company, incorporated in NV. Medinotec Inc. trades on OTC as: MDNC. Based on its latest SEC filing (Form 10-Q, period ending 2026-05-31), Medinotec Inc. reported a 2.51% year-over-year revenue growth, a Gross Profit Margin of 53.90% (TTM), a Debt-to-Equity ratio of 0.19x, a Price-to-Sales (P/S) ratio of 5.74x (TTM), a Price-to-Book (P/B) ratio of 10.04x (TTM), at a market cap of $58.78M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 2.51%
- Gross Profit Margin TTM
- 53.90%
- Debt To Equity
- 0.19x
- P/S TTM
- 5.74x
- P/B TTM
- 10.04x
- Market Cap
- $58.78M
Data as of 2026-05-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Medinotec Inc. in?
Medinotec Inc. (MDNC) operates in the Surgical & Medical Instruments & Apparatus industry.
What is MDNC's market cap?
Medinotec Inc. (MDNC) has a market capitalization of $58.78M as of 2026-05-31.
What is MDNC's P/E ratio?
Medinotec Inc. (MDNC)'s trailing twelve month P/E ratio is 65.11x as of 2026-05-31.
What exchange does MDNC trade on?
Medinotec Inc. (MDNC) trades on the OTC.
Where is Medinotec Inc. incorporated?
Medinotec Inc. is incorporated in NV.